vasoaktive und antiangin se substanzen n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Vasoaktive und antianginöse Substanzen PowerPoint Presentation
Download Presentation
Vasoaktive und antianginöse Substanzen

Loading in 2 Seconds...

play fullscreen
1 / 21

Vasoaktive und antianginöse Substanzen - PowerPoint PPT Presentation


  • 135 Views
  • Uploaded on

Vasoaktive und antianginöse Substanzen. Block 3, KV 14, 21. 12. 2005 H. Porzig Pharmakologisches Institut. Lernziele. Wirkungsmechanismen, Pharmakokinetik und Nebenwirkungen von Antianginosa. Akut wirksame Substanzen Nitrite Prophylaktika b -Blocker Ca 2+ -Kanalblocker

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Vasoaktive und antianginöse Substanzen' - kateb


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
vasoaktive und antiangin se substanzen

Vasoaktive und antianginöse Substanzen

Block 3, KV 14, 21. 12. 2005

H. Porzig

Pharmakologisches Institut

wirkungsmechanismen pharmakokinetik und nebenwirkungen von antianginosa

Lernziele

Wirkungsmechanismen, Pharmakokinetik und Nebenwirkungen von Antianginosa

Akut wirksame Substanzen

Nitrite

Prophylaktika

b-Blocker

Ca2+-Kanalblocker

Plättchenaggregationshemmer

Antihyperlipidämika

definition der angina pectoris who 1957
Definition der Angina Pectoris(WHO, 1957)

„Cardiac disability, acute or chronic, arising from reduction or arrest of blood supply to the myocardium in association with disease processes in the coronary arterial system.“

slide15

Wirkung von Metoprolol auf Herzfrequenz und Ischämiezeiten bei

Patienten mit schwerer koronarer Herzkrankheit